What is CaNCURE?

CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
 Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

66

Trainees

33

Mentors

22

Publications

108

Presentations


Hear from our Alumni:

“I wanted to work on an interesting project and make progress that could give something back to the scientific community. Through this co-op, I was able to achieve that.”

Rachel Fontana, Biochemistry, ’16


Trainee Spotlight


Daem Celestin

Cell and Molecular Biology, '21

The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis

Vivian Zhang

Chemical Eng / Biochemistry, '21

Creating Animal Models of High-grade Serous Ovarian Cancer Cells

Adrienne Orriols

Behavioral Neuroscience, '19

Characterization of Nano-Dinaciclib in Combination with Nano-Talazoparib for the Treatment of Breast Cancer

Featured Trainee Publication


Upcoming Events

Visual Communication: Tips and tricks for effective posters

Tuesday, November 13, 2018

Dr. Anne L van de Ven, Dept of Physics, Northeastern University

435 Egan -- NEU, 3:00 PM


Mentor Spotlight


William Hahn, M.D., Ph.D.

Associate Professor of Medicine, HMS

We have a longstanding interest in cooperative genetic alterations that program malignant transformation and has developed many experimental model systems to study specific genetic alterations. Students will use therapeutic tumor-penetrating siRNA nanocomplexes to identify, validate, and understand potential therapeutic cancer.


Bryan Spring, Ph.D.

Assistant Professor, NEU

The ultimate goal of the program is to reduce cancer recurrence and mortality by establishing new approaches for personalized medicine that address tumor heterogeneity, drug-resistance and molecular mechanisms of treatment escape. Advanced-stage cancer patients are presently subjected to a grueling treatment regimen consisting of surgical tumor debulking and high-dose-intensity chemotherapy. These standard approaches frequently hit a wall due to dose-limiting toxicities as well as mechanisms of drug-resistance and treatment escape via cell signaling networks.


Trainee Spotlight


Nidhi Shankar

Health Science, '19

Molecular Analysis of Plasma Vesicles for Early Pancreatic Cancer Detection

Adrienne Orriols

Behavioral Neuroscience, '19

Characterization of Nano-Dinaciclib in Combination with Nano-Talazoparib for the Treatment of Breast Cancer

Mostafa Abdelhalim

Biochemistry, '21

Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...